Sublayer- and cell-type-specific neurodegenerative transcriptional trajectories in hippocampal sclerosis.

RNAscope calbindin epilepsy fast ripples in vivo recordings sharp-wave ripples single-cell single-nucleus RNAseq temporal lobe epilepsy

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 16 09 2020
revised: 18 03 2021
accepted: 17 05 2021
entrez: 9 6 2021
pubmed: 10 6 2021
medline: 10 2 2022
Statut: ppublish

Résumé

Hippocampal sclerosis, the major neuropathological hallmark of temporal lobe epilepsy, is characterized by different patterns of neuronal loss. The mechanisms of cell-type-specific vulnerability and their progression and histopathological classification remain controversial. Using single-cell electrophysiology in vivo and immediate-early gene expression, we reveal that superficial CA1 pyramidal neurons are overactive in epileptic rodents. Bulk tissue and single-nucleus expression profiling disclose sublayer-specific transcriptomic signatures and robust microglial pro-inflammatory responses. Transcripts regulating neuronal processes such as voltage channels, synaptic signaling, and cell adhesion are deregulated differently by epilepsy across sublayers, whereas neurodegenerative signatures primarily involve superficial cells. Pseudotime analysis of gene expression in single nuclei and in situ validation reveal separated trajectories from health to epilepsy across cell types and identify a subset of superficial cells undergoing a later stage in neurodegeneration. Our findings indicate that sublayer- and cell-type-specific changes associated with selective CA1 neuronal damage contribute to progression of hippocampal sclerosis.

Identifiants

pubmed: 34107264
pii: S2211-1247(21)00580-5
doi: 10.1016/j.celrep.2021.109229
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109229

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Elena Cid (E)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Angel Marquez-Galera (A)

Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550 Sant Joan d'Alacant, Alicante, Spain.

Manuel Valero (M)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Beatriz Gal (B)

Instituto Cajal, CSIC, 28002 Madrid, Spain; Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Madrid, Spain.

Daniel C Medeiros (DC)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Carmen M Navarron (CM)

Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550 Sant Joan d'Alacant, Alicante, Spain.

Luis Ballesteros-Esteban (L)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Rita Reig-Viader (R)

Institut d'Investigació Biomèdica San Pau, 08041 Barcelona, Spain; Universitat Autònoma de Barcelona, 08193 Bellaterra, Cerdanyola del Vallès, Spain.

Aixa V Morales (AV)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Ivan Fernandez-Lamo (I)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Daniel Gomez-Dominguez (D)

Instituto Cajal, CSIC, 28002 Madrid, Spain.

Masaaki Sato (M)

RIKEN Brain Science Institute, Wako, 351-0198 Saitama, Japan.

Yasunori Hayashi (Y)

RIKEN Brain Science Institute, Wako, 351-0198 Saitama, Japan; Department of Pharmacology, Kyoto University Graduate School of Medicine, 606-8501 Kyoto, Japan.

Àlex Bayés (À)

Institut d'Investigació Biomèdica San Pau, 08041 Barcelona, Spain; Universitat Autònoma de Barcelona, 08193 Bellaterra, Cerdanyola del Vallès, Spain.

Angel Barco (A)

Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550 Sant Joan d'Alacant, Alicante, Spain.

Jose P Lopez-Atalaya (JP)

Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550 Sant Joan d'Alacant, Alicante, Spain. Electronic address: jose.lopezatalaya@csic.es.

Liset M de la Prida (LM)

Instituto Cajal, CSIC, 28002 Madrid, Spain. Electronic address: lmprida@cajal.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH